Home > Insider Trading > Filing (0001099219-24-000270)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1099219	Metlife Inc	MET	Life Insurance (6311)	134075851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1770295	Marlene Debel	Metlife, Inc. 200 Park Avenue New York NY 10166	Evp & Chief Risk Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-12-13	13,107	$34.33	121,614	No	4	M	Direct
Common Stock	Acquisiton	2024-12-13	9,703	$45.91	131,317	No	4	M	Direct
Common Stock	Disposition	2024-12-13	22,810	$82.88	108,507	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (right to buy)	Disposition	2024-12-13	13,107	$0.00	13,107	$34.33
Common Stock	Employee Stock Options (right to buy)	Disposition	2024-12-13	9,703	$0.00	9,703	$45.91

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-22	No	4	M	Direct
0		2025-02-23	No	4	M	Direct

Footnotes

The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019.
The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018.